{"code":"Q2056","short_description":"Ciltacabtagene car-pos t","long_description":"Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose","status":"active","section":"Q-codes: Temporary Codes","category":"Temporary","effective_date":"2022-10-01","termination_date":null,"replacement_code":"","opps_status_indicator":"K","opps_status_label":"Non-pass-through drugs and biologicals","opps_apc":"9498","fee_schedules":[],"mue":[],"drug_classes":[],"ndc_crosswalk":[{"ndc":"57894-0111-01","drug_name":"Carvykti","dosage":"UP TO 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells","unit":"1","labeler_name":"Janssen Biotech, Inc."},{"ndc":"57894-0111-02","drug_name":"Carvykti","dosage":"UP TO 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells","unit":"1","labeler_name":"Janssen Biotech, Inc."}],"utilization":[],"urls":{"self_html":"https:\/\/hcpcslookup.com\/codes\/q2056","self_json":"https:\/\/hcpcslookup.com\/api\/codes\/Q2056.json"}}